Geographic Atrophy Market 2025: Detailed Insights into Market Size and Future Growth
30 Apr, 2025
The Geographic Atrophy Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Geographic Atrophy Market?
The market size of the Geographic Atrophy Global Market increased significantly in recent years. The market value will jump from $1.86 billion in 2024 to $2.12 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 13.7%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Geographic Atrophy Industry?
The Geographic Atrophy market is projected to reach $3.50 billion in size by 2029, growing at a compound annual growth rate (CAGR) of 13.5%.
Download Your Free Sample of the 2025 Geographic Atrophy Market Report and Uncover Key Trends Now!What are the Key Growth Drivers Fueling the Geographic Atrophy Market?
The key drivers in the geographic atrophy market are:
• Escalating focus on R&D efforts in Geographic Atrophy
• Rise in investments towards Research and Development
• Surge in the use of smartphones within the medical field
• Increased spending on healthcare services and clinical trials.
Global Market Segmentation: Identifying Major Geographic Atrophy Industry Segments
The geographic atrophy market covered in this report is segmented –
1) By Drug Type: Anti-Vascular Endothelial Growth Factor (VEGF) Therapy, Complement Inhibitors, Neuroprotective Agents, Other Drugs
2) By Diagnosis: Fundus Autofluorescence (FAF), Optical Coherence Tomography Angiography (OCT-A), Multifocal Electroretinography (mfERG)
3) By Route Of Administration: Intravitreal, Oral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
Subsegments:
1) By Anti-Vascular Endothelial Growth Factor (VEGF) Therapy: Ranibizumab, Aflibercept, Bevacizumab
2) By Complement Inhibitors: Pegcetacoplan, Lfg316
3) By Neuroprotective Agents: Latanoprost, Brimonidine
4) By Other Drugs: Steroids, Retinoids, Combination Therapy
What are the emerging Trends Shaping the Future of the Geographic Atrophy Market?
The key trends in the geographic atrophy market are:
• Advances in gene therapy are a key trend for the future of the geographic atrophy market.
• Emerging healthcare technologies are significantly shaping this market.
• The development of new innovative technologies is a major trend.
• The adoption of telemedicine and the development of innovative and effective drugs are growing trends.
Who Are the Top Competitors & Leading Players in the Geographic Atrophy Market?
Major players in the geographic atrophy market are:
• Regeneron Pharmaceuticals Inc.
• Boehringer Ingelheim
• Astellas Pharma Inc.
• Biogen Inc.
• Ocugen Inc.
• Kodiak Sciences Inc.
• Apellis Pharmaceuticals Inc.
• NGM Biopharmaceuticals Inc.
• Voyager Therapeutics
• Kriya Therapeutics
• Stealth BioTherapeutics
• Kiora Pharmaceuticals
• Iveric Bio
• Alkeus Pharmaceuticals
• Nanoscope Therapeutics
• Graybug Vision
• SparingVision
• 4D Molecular Therapeutics
• Clearside Biomedical
• Gensight Biologics
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the geographic atrophy market in 2024